Tekturna (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Tekturna drug offered from Novartis Pharmaceuticals Corporation. This Renin Inhibitor [EPC],Renin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | aliskiren hemifumarate |
SUBSTANCE NAME: | ALISKIREN HEMIFUMARATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Renin Inhibitor [EPC],Renin Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2007-03-05 |
END MARKETING DATE: | 0000-00-00 |
Tekturna HUMAN PRESCRIPTION DRUG Details:
Item Description | Tekturna from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2007-03-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0485_7728a56e-1ef0-48cd-bef7-ff51198e4e63 |
PRODUCT NDC: | 0078-0485 |
APPLICATION NUMBER: | NDA021985 |
Other ALISKIREN HEMIFUMARATE Pharmaceutical Manufacturers / Labelers: